413 related articles for article (PubMed ID: 31595847)
1. Controlled Delivery of Nitric Oxide for Cancer Therapy.
Alimoradi H; Greish K; Gamble AB; Giles GI
Pharm Nanotechnol; 2019; 7(4):279-303. PubMed ID: 31595847
[TBL] [Abstract][Full Text] [Related]
2. Nitric Oxide-Releasing Biomaterials for Biomedical Applications.
Zhou X; Zhang J; Feng G; Shen J; Kong D; Zhao Q
Curr Med Chem; 2016; 23(24):2579-2601. PubMed ID: 27480214
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
Seabra AB; de Lima R; Calderón M
Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
[TBL] [Abstract][Full Text] [Related]
4. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.
Huang Z; Fu J; Zhang Y
J Med Chem; 2017 Sep; 60(18):7617-7635. PubMed ID: 28505442
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery.
Eroy-Reveles AA; Mascharak PK
Future Med Chem; 2009 Nov; 1(8):1497-507. PubMed ID: 21426062
[TBL] [Abstract][Full Text] [Related]
6. NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.
Scicinski J; Oronsky B; Ning S; Knox S; Peehl D; Kim MM; Langecker P; Fanger G
Redox Biol; 2015 Dec; 6():1-8. PubMed ID: 26164533
[TBL] [Abstract][Full Text] [Related]
7. Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.
Andrabi SM; Sharma NS; Karan A; Shahriar SMS; Cordon B; Ma B; Xie J
Adv Sci (Weinh); 2023 Oct; 10(30):e2303259. PubMed ID: 37632708
[TBL] [Abstract][Full Text] [Related]
8. Nitric Oxide and Tumors: From Small-Molecule Donor to Combination Therapy.
Huang W; Zhang J; Luo L; Yu Y; Sun T
ACS Biomater Sci Eng; 2023 Jan; 9(1):139-152. PubMed ID: 36576226
[TBL] [Abstract][Full Text] [Related]
9. Molecular Design and Medicinal Applications of Nano-Nitric Oxide Delivery Systems.
Nguyen KT; Wu Z; Huang T; Tay CY
Curr Med Chem; 2018; 25(12):1420-1432. PubMed ID: 28403790
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-releasing biomaterials for promoting wound healing in impaired diabetic wounds: State of the art and recent trends.
Ahmed R; Augustine R; Chaudhry M; Akhtar UA; Zahid AA; Tariq M; Falahati M; Ahmad IS; Hasan A
Biomed Pharmacother; 2022 May; 149():112707. PubMed ID: 35303565
[TBL] [Abstract][Full Text] [Related]
11. A cyotosol-selective nitric oxide bomb as a new paradigm of an anticancer drug.
Park D; Im S; Saravanakumar G; Lee YM; Kim J; Kim K; Lee J; Kim J; Kim WJ
Chem Commun (Camb); 2019 Dec; 55(98):14789-14792. PubMed ID: 31761922
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the study of nitric oxide-donating drugs].
Zhang YH; Peng SX
Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
[TBL] [Abstract][Full Text] [Related]
13. Hollow S-nitrosothiols nanoparticle with polymeric brushes for nitric oxide (NO)-releasing as tumor targeted chemotherapy.
Wang J; Bi Y; Ruan H; Sun G; Cui X; Yang X; Qin C
J Biomater Sci Polym Ed; 2019 Feb; 30(2):122-136. PubMed ID: 30522414
[TBL] [Abstract][Full Text] [Related]
14. Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.
Nichols SP; Storm WL; Koh A; Schoenfisch MH
Adv Drug Deliv Rev; 2012 Sep; 64(12):1177-88. PubMed ID: 22433782
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
Seabra AB; Durán N
Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide donors: chemical activities and biological applications.
Wang PG; Xian M; Tang X; Wu X; Wen Z; Cai T; Janczuk AJ
Chem Rev; 2002 Apr; 102(4):1091-134. PubMed ID: 11942788
[No Abstract] [Full Text] [Related]
17. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.
Hirst D; Robson T
Curr Pharm Des; 2010; 16(4):411-20. PubMed ID: 20236069
[TBL] [Abstract][Full Text] [Related]
18. Applications for nitric oxide in halting proliferation of tumor cells.
Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
[TBL] [Abstract][Full Text] [Related]
19. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins.
Safdar S; Taite LJ
Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donor hybrid compounds as promising anticancer agents.
Ding QG; Zang J; Gao S; Gao Q; Duan W; Li X; Xu W; Zhang Y
Drug Discov Ther; 2017 Jan; 10(6):276-284. PubMed ID: 27990006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
